Q2 STOCKS TO BUY

Buzz Stocks: J M Smucker Co, Envision Healthcare Holdings Inc, and KemPharm Inc

Today's stocks to watch in the news include J M Smucker Co (SJM), Envision Healthcare Holdings Inc (EVHC), and KemPharm Inc (KMPH)

Jun 9, 2016 at 9:48 AM
facebook X logo linkedin


U.S. stocks are pulling back this morning in step with crude oil. Among equities in focus today are jam giant J M Smucker Co (NYSE:SJM), medical stock Envision Healthcare Holdings Inc (NYSE:EVHC), and drugmaker KemPharm Inc (NASDAQ:KMPH).

  • SJM is 5% higher out of the gate at $140.95, after the company's fiscal fourth-quarter earnings blew past estimates and net sales grew 25% year-over-year. The stock has been stellar in 2016, gaining over 13%, and touched an all-time high of $139.99 earlier. While the stock hasn't received any bullish brokerage attention this morning, it seems like only a matter of time. Among the 13 analysts tracking SJM, nine maintain a tepid "hold" opinion.
  • EVHC has soared 7.9% to trade at $27.68, on reports that the company is in advanced talks to merge with Amsurg Corp (NASDAQ:AMSG) -- a deal that could be announced as early as next week. Envision Healthcare Holdings Inc has been making a steady comeback since hitting a record low of $18.31 in February, and seems to have found a strong ally in the form of its rising 30-day moving average -- from which it bounced repeatedly in May. As such, short sellers have been backing off lately, with these bearish bets falling by 18% during the two most recent reporting periods. The 7.3% of EVHC's float still sold short would take one week to buy back, at the stock's typical daily pace of trading, suggesting there's still more potential for a short-squeeze situation.
  • KMPH is down 7.1% at $6.72 -- and earlier came close to its mid-May record low -- after the company filed an amendment to its New Drug Application (NDA) with the U.S. Food and Drug Administration (FDA) for its Apadaz pain killer. KemPharm Inc wants to provide additional information to the FDA's current review, following the agency's failure to recommend abuse-deterrent labeling in a committee vote last month -- which caused the stock to give up more than half of its value. Despite the stock's recent woes, the three analysts providing coverage all maintain ratings of "buy" or better -- meaning more pain could be coming to KMPH, if these bullish brokerages change their tune.
Sign up now for Schaeffer's Opening View newsletter to get a head start on all the major pre-market news!
 
 

“Buy This Stock Now!” - Expert Who Called 11x On TSLA

He called a rare 11x on Tesla…

But now, thanks to Elon & Trump’s new alliance…

He says there’s a new opportunity that could be 1,000x BIGGER than Tesla – and it could completely revolutionize a $23 Trillion market.

It’s trading for less than $5 per share right now…

But it won’t be under the radar for long.

Discover The 1,000x Bigger Elon Opportunity Here

GRAND SLAM COUNTDOWN

 
 

Featured Articles from Trusted Partners:

👀Learn How Dividends Create Passive Income for Life
Receive $200 Off Motley Fool Epic. The Motley Fool Epic $299 discounted offer is based on $499/year list price. Introductory promotion for new members only. Take control of your money and your portfolio with Motley Fool Epic.

💵New Income System Could Pay You $4,243 Monthly
You could collect an average of $4,243 per month starting as early as next week with a new payout system for income investors. New registrations are being accepted for investors who want to be in a position to start with their first payout next week.

🚀Easy 92% Crypto Dividends (No Coins Required)
COIN stock doesn't pay a dividend... But there's actually a new way to collect a massive dividend that's indirectly based on the stock and offers a terrific monthly income (currently yielding nearly 92% on a forward basis).

🤝Free Advisor Match with Wiseradvisor.com
Don't leave your retirement to chance! Get matched with a trusted financial expert for FREE and make the most of your tax refund. Get started now.

⚠️Dennis Quaid's #1 Warning for Americans
Here's the thing: life doesn't come with guarantees. The economy shifts, markets stumble, and years of hard work could slip through your fingers like sand. But it doesn't have to be that way for you. So request a free copy of this Gold & Silver Guide that will arrive right to your doorstep when you act now.

 

 
 

Follow us on X, Follow us on Twitter